Research Article
Surgical versus Interventional Mitral Valve Repair: Analysis of 1,100 Propensity Score-Matched Patients
Table 1
Patients’ characteristics before and after propensity score matching.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ICD-10: international classification of diseases tenth edition, TMVr: transcatheter mitral valve repair, SMD: standardized mean difference, SD: standard deviation. Cardiovascular medications represents a composite code in TriNetX which include beta blockers, calcium channel blockers, diuretics, ACE inhibitors, ARBs, direct renin inhibitors, sacubitril, hydralazine, clonidine, methyldopa, minoxidil, angiotensin II inhibitors, alpha blockers, milrinone, bosentan, cilostazol, ivabradine, nitroglycerine, isosorbide, antilipemics (including statins, fibrates, cholesterol binding resins, PCSK9 inhibitors), antiarrhythmics, and digoxin. †Antiplatelet medications represents a composite code in TriNetX which includes aspirin, clopidogrel, prasugrel, ticagrelor, cangrelor, and dipyridamole. ‡Anticoagulants represents a composite code in TriNetX which includes warfarin, heparin, low-molecular-weight-heparin, direct factor Xa inhibitors, and direct thrombin inhibitors. |